8:00 am Virtual Coffee & Networking

8:45 am Chair’s Opening Remarks

Optimizing the Promise of DNA-based Vaccines

9:00 am Novel Approaches to Delivering miRNA and siRNAs to Endothelial Cells: From Cancer Immunotherapy to COVID-19 Vaccine

• Ronit Satchi-Fainaro, PhD Head, Cancer Research and Nanomedicine Laboratory, Tel Aviv University

9:30 am Powering a New Decade of DNA-based Vaccines with Optimized Plasmid Design and Delivery

• Jean Boyer, PhD VP Analytical Science, Inovio

10:00 am Optimizing DNA Vaccines Against Emerging Infectious Diseases

• Ami Patel, PhD Research Assistant Professor, The WISTAR Institute

10:30 am Morning Break & Speed Networking

Ushering in a New Era of Vaccinology: mRNA Vaccines

11:00 am Clinical Development of COH04s1 A Multi-Antigen COVID-19 Vaccine Expressed From a Synthetic Modified Vaccinia Ankara Platform

• Don Diamond Professor, Department of Hematology & Hematopoietic Cell Transplantation, City Of Hope,

11:30 am Development of Synthetic mRNA-based Vaccines Against Infectious Diseases Pathogens

• Stefanie Krumm, PhD Associate Director, Infectious Disease Vaccines , BioNTech

12:00 pm Efficient, robust and scalable purification of Covid vaccines based on pDNA, mRNA, Adeno and VLP technologies

• Aleš Štrancar CEO, BIA Separations

12:30 pm Lunch & Virtual Networking Break

1:30 pm ARCT-021, a low dose Self-Replicating RNA based SARS-CoV-2 Prophylactic Vaccine Yielding Effective Protective Immunity

• Sean Sullivan Executive Director, Process Development, Arcturus Therapeutics

Self-replicating RNAs and RNA-based Delivery Methods

2:00 pm Optimization of Lipid Nanoparticles for the Delivery of mRNA Vaccines

• Luis Brito, PhD Senior Director, Formulation Science , Moderna

2:30 pm Replicating RNA as a Platform for Active or Passive Immunization Against Emerging Infectious Diseases

• Jesse Erasmus, PhD Director of Virology , HDT Bio

3:00 pm End of Day Two